Regencell Bioscience Lim... (RGC)
41.00
-17.63 (-30.07%)
At close: Mar 24, 2025, 3:59 PM
41.20
0.49%
After-hours: Mar 24, 2025, 05:16 PM EDT
Regencell Bioscience Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY13 | FY12 | FY11 | FY10 | FY09 | FY07 | FY06 | FY05 | FY04 | FY02 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 3.16B | 3.2B | 3.13B | 2.99B | 3.04B | 2.82B | 2.81B | 2.89B | 2.77B | 2.66B | 2.6B | 2.47B | 2.49B | 2.14B |
| Cost of Revenue | 745.59K | 769.69K | 604.4K | 26.46K | 9.52K | n/a | 123M | 1.23B | 1.21B | 111M | 111M | 101M | 101M | 1.16B | 106M | 103M | 104M | 94M | 92M | 84M |
| Gross Profit | -745.59K | -769.69K | -604.4K | -26.46K | -9.52K | n/a | 3.04B | 1.97B | 1.92B | 2.88B | 2.93B | 2.72B | 2.71B | 1.74B | 2.67B | 2.56B | 2.49B | 2.37B | 2.4B | 2.06B |
| Operating Income | -4.74M | -6.27M | -7.62M | -1.38M | -812.37K | -390.99K | 271.7M | 344.2M | 339M | 306.4M | 339.8M | 334.2M | 215.8M | 313.4M | 284M | 322M | 308M | 321M | 379M | 283M |
| Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -4.36M | -6.06M | -7.59M | -1.35M | -812.37K | -390.99K | 213.9M | 281.7M | 253.3M | 178.6M | 264.6M | 235.9M | 75.7M | 157.2M | 123M | 605M | 144M | 142M | 306M | 208M |
| Net Income | -4.3M | -5.87M | -7.42M | -1.35M | -812.37K | -390.99K | 112.3M | 170.4M | 153.4M | 105.6M | 157.7M | 144.8M | 77.6M | 95.5M | 72M | 363M | 86M | 82M | 185M | 117M |
| Selling & General & Admin | 2.92M | 4.69M | 5.11M | 943.04K | 426.14K | 162.77K | 86.6M | 512.2M | 500.3M | 74.4M | 73.7M | 68.8M | 66.7M | 443M | 62M | 63M | 65M | 63M | 62M | 65M |
| Research & Development | 1.07M | 1.58M | 2.51M | 438.32K | 386.23K | 228.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | 211.34K | 23.21K | 34.62K | n/a | n/a | 1.22B | 1.11B | 1.08B | 1.12B | 1.09B | 985.3M | 1.17B | 980.4M | 2.42B | 2.28B | 2.22B | 2.08B | 2.05B | 1.79B |
| Operating Expenses | 3.99M | 6.27M | 7.62M | 1.38M | 812.37K | 390.99K | 1.31B | 1.63B | 1.58B | 1.19B | 1.16B | 1.05B | 1.23B | 1.42B | 2.49B | 2.34B | 2.29B | 2.15B | 2.11B | 1.86B |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 152.8M | -124M | -112M | -125M | -95M | -72M | 61M |
| Selling & Marketing Expenses | 125.43K | 262.66K | 25.27K | 1.58K | 114.21K | 3.64K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 4.74M | 6.27M | 7.62M | 1.38M | 812.37K | 390.99K | 2.89B | 2.85B | 2.79B | 2.68B | 2.7B | 2.49B | 2.59B | 2.58B | 2.59B | 2.44B | 2.39B | 2.24B | 2.2B | 1.94B |
| Income Tax | n/a | -191.2K | -171.83K | -210.1K | -1 | -390.99 | 101.6M | 111.2M | 100.1M | 73.4M | 107M | 91.2M | 48.7M | 61.9M | 50M | 242M | 57M | 59M | 121M | 89M |
| Shares Outstanding (Basic) | 13.01M | 13.01M | 13.01M | 12.64M | 12.64M | 12.64M | 156.34M | 156.79M | 156.45M | 155.29M | 154.83M | 154.17M | 153.4M | 153.05M | 1.16M | 5.75M | 1.31M | 143.86M | 138.06M | 140.96M |
| Shares Outstanding (Diluted) | 13.01M | 13.01M | 13.01M | 12.64M | 12.64M | 12.64M | 156.99M | 156.8M | 156.5M | 156.31M | 155.72M | 154.99M | 154.52M | 154.1M | 1.16M | 5.75M | 1.31M | 149.09M | 142.31M | 148.1M |
| EPS (Basic) | -0.33 | -0.45 | -0.57 | -0.11 | -0.06 | -0.03 | 0.72 | 1.09 | 0.98 | 0.68 | 1.02 | 0.94 | 0.51 | 0.62 | 62.10 | 63.10 | 65.90 | 0.57 | 1.34 | 0.83 |
| EPS (Diluted) | -0.33 | -0.45 | -0.57 | -0.11 | -0.06 | -0.03 | 0.72 | 1.09 | 0.98 | 0.68 | 1.01 | 0.93 | 0.50 | 0.62 | 62.10 | 63.10 | 65.90 | 0.55 | 1.30 | 0.79 |
| EBITDA | -3.62M | -5.29M | -6.99M | -1.35M | -802.86K | -390.99K | 468.7M | 512.3M | 470.3M | 391M | 469.2M | 422.2M | 352.5M | 512.1M | 200M | 676M | 215M | 220M | 392M | 401M |
| Depreciation & Amortization | 745.59K | 769.69K | 604.4K | 26.46K | 9.52K | 390.99K | 254.8M | 230.7M | 216.8M | 212M | 204.5M | 186.2M | 226.2M | 201.9M | 202M | 183M | 197M | 174M | 158M | 134M |